Sleep duration and lipid metabolism in patients with diabetes mellitus: from the POWER2DM study
- Perez-Corral, I.
- Gomez-Delgado, F.
- Ruissen, M.M.
- Torres-Pena, J.D.
- Arenas-de Larriva, A.P.
- Sont, J.K.
- Graaf, A.A. de
- Uitbeijerse, B.S.
- Koning, E.J.P. de
- Delgado-Lista, J.
Publication date
August 2022
DOI Publisher
Springer Science and Business Media LLCAbstract
This study assesses the association between sleep duration and plasma lipid profiles in people with diabetes mellitus (DM). Sleep duration data were obtained in 91 patients from the POWER2DM study (NCT03588104). The patients were divided in tertiles, based on their sleep duration, and blood samples were obtained at the beginning and after 9 months. Significant differences were found, specifically, patients in Tertile 3 (>= 7.51 h) showed lower plasma levels of high-density lipoprotein cholesterol HDL-c (p < 0.05), apolipoprotein A1 (apo-A1; p < 0.05) and low HDL-c/apo-A1 ratio (p < 0.05). This study shows that sleep duration is associated with plasma lipid profiles in people with DM
Add to ORKG